Author: David J. CoonerPublisher:
ISBN:
Category : Products liability
Languages : en
Pages : 169
Book Description
The Restatement Sections Specifically Applicable to Pharmaceutical and Medical Device Cases in State Court
Author: David J. CoonerPublisher:
ISBN:
Category : Products liability
Languages : en
Pages : 169
Book Description
Drug and Medical Device Product Liability Deskbook
Author: James BeckPublisher: Law Journal Press
ISBN: 9781588521217
Category : Actions and defenses
Languages : en
Pages : 982
Book Description
This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.
New Medical Devices
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309038472
Category : Medical
Languages : en
Pages : 203
Book Description
In the past 50 years the development of a wide range of medical devices has improved the quality of people's lives and revolutionized the prevention and treatment of disease, but it also has contributed to the high cost of health care. Issues that shape the invention of new medical devices and affect their introduction and use are explored in this volume. The authors examine the role of federal support, the decision-making process behind private funding, the need for reforms in regulation and product liability, the effects of the medical payment system, and other critical topics relevant to the development of new devices.
Women and Health Research
Author: Anna C. MastroianniPublisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 268
Book Description
Model Rules of Professional Conduct
Author: American Bar Association. House of DelegatesPublisher: American Bar Association
ISBN: 9781590318737
Category : Law
Languages : en
Pages : 216
Book Description
The Model Rules of Professional Conduct provides an up-to-date resource for information on legal ethics. Federal, state and local courts in all jurisdictions look to the Rules for guidance in solving lawyer malpractice cases, disciplinary actions, disqualification issues, sanctions questions and much more. In this volume, black-letter Rules of Professional Conduct are followed by numbered Comments that explain each Rule's purpose and provide suggestions for its practical application. The Rules will help you identify proper conduct in a variety of given situations, review those instances where discretionary action is possible, and define the nature of the relationship between you and your clients, colleagues and the courts.
Registries for Evaluating Patient Outcomes
Author: Agency for Healthcare Research and Quality/AHRQPublisher: Government Printing Office
ISBN: 1587634333
Category : Medical
Languages : en
Pages : 385
Book Description
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.
Guidelines Manual
Author: United States Sentencing CommissionPublisher:
ISBN:
Category : Criminal justice, Administration of
Languages : en
Pages : 556
Book Description
General Considerations for the Clinical Evaluation of Drugs
Author: United States. Food and Drug Administration. Bureau of DrugsPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 20
Book Description
The Future of Drug Safety
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309133947
Category : Medical
Languages : en
Pages : 346
Book Description
In the wake of publicity and congressional attention to drug safety issues, the Food and Drug Administration (FDA) requested the Institute of Medicine assess the drug safety system. The committee reported that a lack of clear regulatory authority, chronic underfunding, organizational problems, and a scarcity of post-approval data about drugs' risks and benefits have hampered the FDA's ability to evaluate and address the safety of prescription drugs after they have reached the market. Noting that resources and therefore efforts to monitor medications' riskâ€"benefit profiles taper off after approval, The Future of Drug Safety offers a broad set of recommendations to ensure that consideration of safety extends from before product approval through the entire time the product is marketed and used.
Author: Texas